91 results
424B2
PYXS
Pyxis Oncology Inc
3 Apr 24
Prospectus for primary offering
8:45pm
were incorporated in the state of Delaware on June 11, 2018 and launched with our first employee and Series A funding in July 2019. Our principal
8-K
EX-10.1
j5lz2akf
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.2
qyx vxfm5858sb0pj
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
rni25pnjzc4lec64
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
8-K/A
EX-99.1
fbsv5qnm
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-99.2
q2kylhdbjfnnmrwkf
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
S-8 POS
EX-4.5
i988u6waips69
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
EX-4.3
re5a2 hjs4
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
EX-4.4
1pnie
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
r2bd5n
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
POS AM
EX-4.7
kh2kco
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
POS AM
usig42 zh
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm